Equivalence Trials as Topic
"Equivalence Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about trials that aim to show a new treatment is no better and no worse than the standard treatment.
| Descriptor ID |
D000074099
|
| MeSH Number(s) |
E05.318.760.250.500.365.500.125 N05.715.360.775.088.500.387.500.250 N06.850.520.450.250.250.365.500.250
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Equivalence Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Equivalence Trials as Topic".
This graph shows the total number of publications written about "Equivalence Trials as Topic" by people in this website by year, and whether "Equivalence Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Equivalence Trials as Topic" by people in Profiles.
-
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study. Lancet Haematol. 2016 Sep; 3(9):e437-45.
-
Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial. Lancet Haematol. 2016 Aug; 3(8):e379-87.